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A’Hern’s and Jung’s single stage designs are phase II trial
designs based on dichotomous outcomes. They are used
in the single arm and randomised settings respectively.
Decision rules at the end of the study are based on a
required number of either treatment successes or extra
successes on the treatment arm. They are exact designs in
that the power and alpha can be calculated directly using
binomial probabilities. Typically one would choose the
power and alpha and then pick the smallest sample size
that meets these restrictions. The discrete nature of the set
of possible decision rules results in a somewhat erratic
behaviour of the calculated sample sizes. In some situa-
tions, small changes to the design parameters can result in
important reductions in sample size. Possible changes
include relaxing one’s alpha / beta slightly, or using inter-
mediate stopping rules (eg Jung’s / Simon’s minimax
designs). When designing these studies it is helpful to be
aware of these issues and take account of them, so as to
keep the sample sizes as small as possible.
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